MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Laboratory Corporation of America Holdings Operating Cycle 2011-2026 | LH
Annual Operating Cycle Laboratory Corporation of America Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71.8 | 72.9 | 75.1 | 81.8 | 84.3 | 66 | 74.7 | 70.6 | 71.9 | 69.1 | 69.9 | 62.9 | 63.2 | 59.1 | 58.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 84.3 | 58.5 | 70.1 |
Quarterly Operating Cycle Laboratory Corporation of America Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 72.7 | 73.2 | 74.2 | - | 75.4 | 77.3 | 76.4 | - | 77.3 | 84.1 | 81.9 | - | 45.2 | 45.1 | 67.1 | - | 65.2 | 68.9 | 67.8 | - | 74.6 | 101 | 79.5 | 47.7 | 58.7 | 59.8 | 60.2 | 48 | 57.9 | 57.4 | 58.3 | 51.7 | 65.1 | 68.2 | 66.2 | 50.8 | 62.6 | 62.6 | 62 | 49.5 | 60.2 | 61.7 | 65.3 | 49.2 | 61 | 62.5 | 54.4 | 49.8 | 62.6 | 62.8 | 61.1 | 46.6 | 59 | 59.1 | 57.9 | 46.7 | 57.6 | 57.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 | 45.1 | 62.8 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
161 | $ 115.48 | 0.82 % | $ 35.1 B |  USA |
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 16.2 | -0.61 % | $ 175 M |  China |
|
Biodesix
BDSX
|
41.7 | $ 15.07 | 2.1 % | $ 1.95 B | USA |
 |
Aspira Women's Health
AWH
|
1.2 K | - | -6.19 % | $ 10.5 M | USA |
 |
Co-Diagnostics
CODX
|
1.79 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 24.84 | -0.84 % | $ 690 M | USA |
 |
DarioHealth Corp.
DRIO
|
227 | $ 8.4 | 3.7 % | $ 33.5 M |  Israel |
 |
BioNano Genomics
BNGO
|
315 | $ 1.2 | 0.84 % | $ 6.53 M | USA |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Charles River Laboratories International
CRL
|
65 | $ 173.89 | -0.58 % | $ 8.62 B | USA |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | USA |
 |
DexCom
DXCM
|
202 | $ 62.22 | -0.24 % | $ 24.3 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 16.82 | 2.31 % | $ 509 M | USA |
 |
Biomerica
BMRA
|
204 | $ 2.17 | -0.91 % | $ 4.98 M | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
54.2 | $ 198.02 | 0.17 % | $ 22 B | USA |
 |
Guardant Health
GH
|
128 | $ 93.83 | 2.94 % | $ 11.8 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
121 | $ 76.1 | 0.53 % | $ 5.14 B | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
Medpace Holdings
MEDP
|
50.4 | $ 498.34 | 1.81 % | $ 14.4 B | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
96 | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Mettler-Toledo International
MTD
|
66.4 | $ 1 259.94 | -1.11 % | $ 26 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 114.19 | 2.49 % | $ 9.42 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
128 | $ 569.55 | 0.87 % | $ 45.8 B | USA |
 |
Neogen Corporation
NEOG
|
213 | $ 9.41 | 0.21 % | $ 2.04 B | USA |
 |
Illumina
ILMN
|
198 | $ 127.38 | 0.59 % | $ 20.3 B | USA |
 |
IQVIA Holdings
IQV
|
73.9 | $ 173.26 | 0.5 % | $ 29.8 B | USA |
 |
Pacific Biosciences of California
PACB
|
244 | $ 1.34 | -0.74 % | $ 402 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 27.11 | -0.66 % | $ 20 B |  Niderland |
 |
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Myriad Genetics
MYGN
|
95.1 | $ 4.75 | 3.49 % | $ 440 M | USA |
 |
Sotera Health Company
SHC
|
80.3 | $ 14.96 | 0.61 % | $ 4.25 B | USA |
 |
NeoGenomics
NEO
|
102 | $ 8.0 | 3.23 % | $ 1.02 B | USA |
 |
National Research Corporation
NRC
|
29.4 | $ 17.16 | -1.04 % | $ 384 M | USA |